The effect of prolonged GnRH agonist (GnRHa) therapy on in vitro fertilization-embryo transfer (IVF-ET) cycle outcome in endometriosis (ENDO) patients: a multicenter randomized trial.
article
OA: closed
CC0
⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This multicenter randomized trial investigated the impact of prolonged GnRH agonist therapy on in vitro fertilization-embryo transfer outcomes in patients with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (3)
- Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis 2019
- Endometriosis and Assisted Reproductive Technologies: Maximizing Outcomes 2013
- Does Surgical Management of Endometriosis Within 6 Months of an In Vitro Fertilization–Embryo Transfer Cycle Improve Outcome? 2003
Cited by (3)
- Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis 2019
- Endometriosis and Assisted Reproductive Technologies: Maximizing Outcomes 2013
- Does Surgical Management of Endometriosis Within 6 Months of an In Vitro Fertilization–Embryo Transfer Cycle Improve Outcome? 2003
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK